From around the age of 40\u201345, many people begin making an almost unconscious movement: holding their phone farther away in order to read it.<\/p>\n
This is presbyopia.<\/p>\n
For decades, the available solutions have been mainly optical or surgical: reading glasses, progressive lenses, contact lenses or, in selected patients, different surgical procedures.<\/p>\n
In recent years, however, a completely different alternative has emerged: eye drops capable of temporarily improving near vision<\/strong>.<\/p>\n The obvious question is whether they really work.<\/p>\n The answer is yes, but with important qualifications<\/strong>.<\/p>\n When we are young, the crystalline lens can change its shape to focus on objects at different distances. This mechanism is known as accommodation.<\/p>\n With age, the system progressively loses this ability and focusing at near becomes increasingly difficult.<\/p>\n We initially need more light to read, then begin holding text farther away and eventually require optical correction for near vision.<\/p>\n This is the most interesting part.<\/p>\n Currently available eye drops do not restore the youthful accommodative ability of the crystalline lens<\/strong>.<\/p>\n Their principal mechanism is different.<\/p>\n Certain drugs produce a controlled reduction in pupil size. A smaller pupil creates an optical effect similar to reducing the aperture of a camera: it increases depth of focus<\/strong>.<\/p>\n Near vision can therefore improve while maintaining functional distance vision.<\/p>\n This is known as the pinhole effect<\/strong>.<\/p>\n The patient may read better, but the crystalline lens has not become younger.<\/p>\n Pilocarpine was the first drug approved by the FDA specifically for presbyopia.<\/p>\n Its efficacy is now supported by a substantial body of clinical evidence.<\/p>\n A meta-analysis published in American Journal of Ophthalmology<\/em> included four randomised trials involving 1,531 participants.<\/p>\n This demonstrates that the effect is not merely subjective.<\/p>\n A smaller pupil increases depth of focus but also allows less light to enter the eye.<\/p>\n Some patients may therefore notice reduced visual quality in dim illumination.<\/p>\n A smaller pupil may compromise visual quality in poorly lit environments.<\/p>\n Headache is one of the most commonly reported adverse effects.<\/p>\n Temporary episodes of blurred vision have been reported in some patients.<\/p>\n Mild and transient ocular discomfort may occur.<\/p>\n There is another issue ophthalmologists must consider carefully.<\/p>\n Cases of vitreomacular traction and retinal detachment have been reported in temporal association with pilocarpine used for presbyopia.<\/p>\n This does not mean they are common, but it supports appropriate patient selection and particular caution in people with retinal risk factors.<\/p>\n In July 2025, the FDA approved an ophthalmic solution containing aceclidine<\/strong> for treating presbyopia in adults.<\/p>\n Its particular interest lies in producing significant miosis with comparatively less effect on the ciliary muscle.<\/p>\n The available evidence includes:<\/p>\n The pooled data demonstrate a significantly greater likelihood of improving near vision compared with placebo.<\/p>\n However, larger studies and long-term follow-up remain necessary.<\/p>\n No.<\/p>\n It is more accurate to regard these treatments as a new option<\/strong> rather than a universal replacement for spectacles.<\/p>\n Their effect is temporary.<\/p>\n Response depends on several individual factors:<\/p>\n Some patients may find them useful for specific situations, while others will continue to prefer glasses.<\/p>\n These medications should not simply be viewed as drops to purchase and try without professional assessment.<\/p>\n Before using a drug that modifies pupil size, it is reasonable to understand the patient\u2019s ocular status.<\/p>\n The peripheral retina deserves particular attention in individuals with:<\/p>\n Night-driving requirements and other situations demanding high-quality vision should also be taken into account.<\/p>\n Personalised medicine remains essential.<\/p>\n We are probably witnessing the beginning of a new therapeutic category<\/strong>.<\/p>\n For decades, presbyopia management focused on placing a lens in front of or inside the eye, or surgically altering the optical system.<\/p>\n Today, we can temporarily modify the eye\u2019s own optics pharmacologically.<\/p>\n Research continues into treatments that are more selective, longer lasting and associated with fewer adverse effects.<\/p>\n However, perspective is important.<\/p>\n Current drops temporarily improve near vision; they have not been shown to reverse ageing of the crystalline lens<\/strong>.<\/p>\n Yes, eye drops capable of improving near vision in people with presbyopia now exist, and randomised clinical trials demonstrate genuine efficacy.<\/p>\n However, they do not cure presbyopia.<\/p>\n Their effect is achieved primarily by reducing pupil size and increasing depth of focus.<\/p>\n The real question may no longer be whether reading glasses will disappear, but whether we will be able to choose when we need them.<\/strong><\/p>\n No. They may temporarily improve near vision in selected individuals, but they are not a universal replacement for reading glasses.<\/p>\n Most work by reducing pupil size, increasing depth of focus and improving near vision without reversing lens ageing.<\/p>\n Reported side effects include headache, blurred vision, ocular pain and reduced visual quality under low-light conditions.<\/p>\n No. An ophthalmological evaluation is recommended to assess retinal health, visual requirements and individual risk factors.<\/p>\n No. They temporarily improve near vision but do not restore the youthful accommodative capacity of the crystalline lens.<\/p>\n Content written and reviewed by Antonio Soler<\/strong>, ophthalmic surgeon and Medical Director of Soleyes Eye Clinic.<\/p>\n This article is provided for informational purposes only and does not replace an individual medical consultation. Every patient requires a comprehensive ophthalmological evaluation before deciding on the most appropriate treatment.<\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":" Presbyopia Eye Drops: Could We Read Without Glasses Again? From around the age of 40\u201345, many people begin making an<\/p>\n","protected":false},"author":1,"featured_media":9973,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_joinchat":[],"footnotes":""},"categories":[154],"tags":[],"class_list":["post-9976","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-eye-doctors-advice"],"_links":{"self":[{"href":"https:\/\/soleyes.es\/en\/wp-json\/wp\/v2\/posts\/9976","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/soleyes.es\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/soleyes.es\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/soleyes.es\/en\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/soleyes.es\/en\/wp-json\/wp\/v2\/comments?post=9976"}],"version-history":[{"count":1,"href":"https:\/\/soleyes.es\/en\/wp-json\/wp\/v2\/posts\/9976\/revisions"}],"predecessor-version":[{"id":9977,"href":"https:\/\/soleyes.es\/en\/wp-json\/wp\/v2\/posts\/9976\/revisions\/9977"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/soleyes.es\/en\/wp-json\/wp\/v2\/media\/9973"}],"wp:attachment":[{"href":"https:\/\/soleyes.es\/en\/wp-json\/wp\/v2\/media?parent=9976"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/soleyes.es\/en\/wp-json\/wp\/v2\/categories?post=9976"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/soleyes.es\/en\/wp-json\/wp\/v2\/tags?post=9976"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}Eye Drops for Presbyopia: Could We Read Again Without Glasses?<\/h2>\n
Why Does Presbyopia Develop?<\/h2>\n
How Can an Eye Drop Improve Near Vision?<\/h2>\n
Pilocarpine: The First Generation<\/h2>\n
\n
The Limitation: Miosis Also Has Consequences<\/h2>\n
Reduced Vision in Low-Light Conditions<\/h3>\n
Headache<\/h3>\n
Blurred Vision<\/h3>\n
Ocular Pain<\/h3>\n
Aceclidine: A New Generation<\/h2>\n
\n
Does This Mean the End of Reading Glasses?<\/h2>\n
\n
Who Should Use These Drops?<\/h2>\n
\n
Are These Drops the Future of Presbyopia Treatment?<\/h2>\n
Summary<\/h2>\n
Frequently Asked Questions About Presbyopia Eye Drops<\/h2>\n
Can presbyopia eye drops replace reading glasses?<\/h3>\n
How do presbyopia eye drops work?<\/h3>\n
What side effects can occur?<\/h3>\n
Are these drops suitable for everyone with presbyopia?<\/h3>\n
Do presbyopia eye drops cure age-related near vision loss?<\/h3>\n
\nMedically Reviewed Content<\/h2>\n